1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors
Klopfenstein, S.R., Evdokimov, A.G., Colson, A.-O., Fairweather, N.T., Neuman, J.J., Maier, M.B., Gray, J.L., Gerwe, G.S., Stake, G.E., Howard, B.W., Farmer, J.A., Pokross, M.E., Downs, T.R., Kasibhatla, B., Peters, K.G.(2006) Bioorg Med Chem Lett 16: 1574-1578
- PubMed: 16386905 
- DOI: https://doi.org/10.1016/j.bmcl.2005.12.051
- Primary Citation of Related Structures:  
2F6T, 2F6V, 2F6W, 2F6Y, 2F6Z, 2F70, 2F71 - PubMed Abstract: 
High-throughput screening of the P&GP corporate repository against several protein tyrosine phosphatases identified the sulfamic acid moiety as potential phosphotyrosine mimetic. Incorporation of the sulfamic acid onto a 1,2,3,4-tetrahydroisoquinoline scaffold provided a promising starting point for PTP1B inhibitor design.
Organizational Affiliation: 
Procter & Gamble Pharmaceuticals, Health Care Research Center, 8700 Mason-Montgomery Road, Mason, OH 45040, USA. klopfenstein.sr@pg.com